Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Niraparib in Cancer
NCT02476552Phase 1Completed
- Start
- Feb 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of niraparib in solid tumor (2 arms). Primary endpoint: Oral bioavailability (F). Started Feb 2015; status: completed.
02
Drugs
niraparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02476552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476552.